Twist Bioscience at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
Twist Bioscience takes part in 3 sessions at Antibody Engineering 2026 in San Diego, and exhibits at Booth 200. Its program covers lab testing at the scale AI-based biologic discovery needs, and building bispecific antibodies with its B-Body platform. It also shows cell-free expression of full-length IgG, so screening happens in the format a program will develop.
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
Twist Bioscience South San Francisco, CA | |
Synthetic DNA company whose biopharma unit provides antibody libraries and antibody discovery and optimization services. | Booth Exhibiting at Booth 200 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Mon Dec 14 12:15pm–1:15pm Scaling Wet-Lab Validation for AI-based Biologic Discovery Why lab testing has become the bottleneck for AI antibody design, and how a shared model platform from Eli Lilly connects to it. AI & computational designAntibody discovery Talk Tue Dec 15 1:40pm–2:00pm Screening in the Format You’ll Develop In: Cell-Free Expression of Full-Length IgG Making full-length antibodies without cells at screening scale, and how their binding compares with the same antibodies made in mammalian cells. Antibody discovery Talk Wed Dec 16 7:30am–8:00am Engineering for Better Bispecifics: Introducing the B-Body® Platform A two-target antibody design meant to assemble reliably, avoiding low yields and hard purification when production scales up. Bispecifics & multispecificsDevelopability & CMC |
Find decision makers at Twist Bioscience
Tell us what you sell and we’ll find the people at Twist Bioscience most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction